Equity Capital Markets

Company · CIK 1015820

QIAGEN N.V.

CIK1015820 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inP7
ListedQGEN (NYSE)
First annual or quarterly report2002-04-02

Offerings

0 registrations

No offering chain starts here after 2002-11-04: the company's filings belong to registrations filed earlier, or to drafts and notices only.

Filings

6
FiledFilingRegistrationAccession
2009-09-25424B5Shelf takedown 333-1620520001193125-09-198241
2009-09-23424B5Shelf takedown 333-1620520001193125-09-196144
2007-07-23EFFECTDeclared effective 333-1437919999999995-07-002928
2007-06-06EFFECTDeclared effective 333-1428689999999995-07-002268
2003-03-27RWWithdrawn 333-123240000927016-03-001408
2003-03-27RWWithdrawn 333-914740000927016-03-001407

All filings of this company · CSV